Compare MLAB & IBEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MLAB | IBEX |
|---|---|---|
| Founded | 1982 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | EDP Services |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 489.8M | 489.1M |
| IPO Year | N/A | 2020 |
| Metric | MLAB | IBEX |
|---|---|---|
| Price | $93.08 | $34.25 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 3 |
| Target Price | ★ $94.00 | $31.33 |
| AVG Volume (30 Days) | 94.2K | ★ 130.4K |
| Earning Date | 02-03-2026 | 02-05-2026 |
| Dividend Yield | ★ 0.70% | N/A |
| EPS Growth | N/A | ★ 42.47 |
| EPS | 0.68 | ★ 3.04 |
| Revenue | $247,541,000.00 | ★ $603,274,000.00 |
| Revenue This Year | $4.96 | $12.15 |
| Revenue Next Year | $4.85 | $5.68 |
| P/E Ratio | $134.88 | ★ $11.26 |
| Revenue Growth | 4.12 | ★ 15.63 |
| 52 Week Low | $55.45 | $21.64 |
| 52 Week High | $155.12 | $42.99 |
| Indicator | MLAB | IBEX |
|---|---|---|
| Relative Strength Index (RSI) | 65.05 | 52.11 |
| Support Level | $77.48 | $32.53 |
| Resistance Level | $98.14 | $38.59 |
| Average True Range (ATR) | 3.89 | 1.80 |
| MACD | 0.84 | -0.26 |
| Stochastic Oscillator | 68.60 | 63.71 |
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.